NOVEL APPROACHES TO ADDRESS RESISTANCE TO ANTI PD-1/PD-L1 THERAPY IN NSCLC

被引：0
|
作者：
Sehgal, M. [1 ]
Das, N. [1 ]
Thekkadath, R. [1 ]
Mittal, N. [1 ]
Chauhan, U. [1 ]
Eswaran, S. [1 ]
机构：
[1] COURSE5 Intelligence Pvt Ltd, Bengaluru, KA, India
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN46
引用
收藏
页码：S444 / S444
页数：1
相关论文
共 50 条
  • [41] Oncolytic virus and PD-1/PD-L1 blockade combination therapy
    Chen, Chun-Yu
    Hutzen, Brian
    Wedekind, Mary F.
    Cripe, Timothy P.
    ONCOLYTIC VIROTHERAPY, 2018, 7 : 65 - 77
  • [42] Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway
    Wang, Zhijie
    Yuan, Lin
    Liao, Xiaotong
    Guo, Xia
    Chen, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (08) : 6027 - 6043
  • [43] PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma
    Sonpavde, Guru
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (11): : 1073 - 1074
  • [44] The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
    Xueping Wang
    Fang Wang
    Mengjun Zhong
    Yosef Yarden
    Liwu Fu
    Molecular Cancer, 19
  • [45] Photodynamic Therapy enhances the Effect of PD-1/PD-L1 Inhibitors
    Erhard, Daniela
    AKTUELLE DERMATOLOGIE, 2019, 45 (07) : 316 - 316
  • [46] The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
    Wang, Xueping
    Wang, Fang
    Zhong, Mengjun
    Yarden, Yosef
    Fu, Liwu
    MOLECULAR CANCER, 2020, 19 (01)
  • [47] PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer
    Yaghoubi, Neda
    Soltani, Arash
    Ghazvini, Kiarash
    Hassanian, Seyed Mahdi
    Hashemy, Seyed Isaac
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 312 - 318
  • [48] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
  • [49] Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction
    Zhang, Feng
    Yu, Qimeng
    Wu, Caiyun
    Sun, Shishi
    Wang, Yu
    Wang, Rui
    Chen, Zejie
    Zhang, Hua
    Xiong, Xuqiong
    Awadasseid, Annoor
    Rao, Guowu
    Zhao, Xiaoyin
    Zhang, Wen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 111
  • [50] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Linhares, Annika De Sousa
    Battin, Claire
    Jutz, Sabrina
    Leitner, Judith
    Hafner, Christine
    Tobias, Joshua
    Wiedermann, Ursula
    Kundi, Michael
    Zlabinger, Gerhard J.
    Grabmeier-Pfistershammer, Katharina
    Steinberger, Peter
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345